Multiple Sclerosis Stocks List

Recent Signals

Date Stock Signal Type
2019-11-13 ACOR Narrow Range Bar Range Contraction
2019-11-13 ACOR NR7 Range Contraction
2019-11-13 ACOR Calm After Storm Range Contraction
2019-11-13 ALKS Fell Below 50 DMA Bearish
2019-11-13 ALKS Fell Below 20 DMA Bearish
2019-11-13 BCLI Doji - Bearish? Reversal
2019-11-13 BWAY Narrow Range Bar Range Contraction
2019-11-13 BWAY NR7 Range Contraction
2019-11-13 BWAY MACD Bearish Centerline Cross Bearish
2019-11-13 CGEN 1,2,3 Pullback Bullish Bullish Swing Setup
2019-11-13 CGEN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-13 DPLO MACD Bearish Centerline Cross Bearish
2019-11-13 DPLO Calm After Storm Range Contraction
2019-11-13 DPLO Volume Surge Other
2019-11-13 FWP 180 Bearish Setup Bearish Swing Setup
2019-11-13 FWP Stochastic Reached Oversold Weakness
2019-11-13 GMAB New 52 Week Closing High Bullish
2019-11-13 GMAB Doji - Bearish? Reversal
2019-11-13 GMAB New 52 Week High Strength
2019-11-13 IMUX Bollinger Band Squeeze Range Contraction
2019-11-13 IMUX Lower Bollinger Band Walk Weakness
2019-11-13 IONS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-13 MGLN Pocket Pivot Bullish Swing Setup
2019-11-13 MYO Fell Below 50 DMA Bearish
2019-11-13 MYO New 52 Week Low Weakness
2019-11-13 MYO Volume Surge Other
2019-11-13 MYO Spinning Top Other
2019-11-13 MYO New 52 Week Closing Low Bearish
2019-11-13 MYO Stochastic Sell Signal Bearish
2019-11-13 MYO MACD Bearish Centerline Cross Bearish
2019-11-13 MYO Upper Bollinger Band Walk Strength
2019-11-13 MYO Fell Below 20 DMA Bearish
2019-11-13 PFNX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-11-13 PFNX 1,2,3 Pullback Bullish Bullish Swing Setup
2019-11-13 PFNX 20 DMA Support Bullish
2019-11-13 PFNX MACD Bearish Signal Line Cross Bearish
2019-11-13 PRTK Fell Below 50 DMA Bearish
2019-11-13 PRTK 20 DMA Support Bullish
2019-11-13 PSTI Volume Surge Other
2019-11-13 PSTI New 52 Week Low Weakness
2019-11-13 PSTI New 52 Week Closing Low Bearish
2019-11-13 SNY Bollinger Band Squeeze Range Contraction
2019-11-13 SYN Crossed Above 20 DMA Bullish
2019-11-13 SYN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-13 TEVA Pocket Pivot Bullish Swing Setup
2019-11-13 TEVA Upper Bollinger Band Walk Strength
2019-11-13 TEVA Calm After Storm Range Contraction
2019-11-13 VCNX Reversal New Lows Setup Bearish Swing Setup
2019-11-13 VCNX 180 Bearish Setup Bearish Swing Setup
2019-11-13 VCNX 20 DMA Resistance Bearish
2019-11-13 VCNX Stochastic Reached Oversold Weakness
2019-11-13 VCNX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-11-13 VCNX Expansion Breakdown Bearish Swing Setup

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.While the cause is not clear, the underlying mechanism is thought to be either destruction by the immune system or failure of the myelin-producing cells. Proposed causes for this include genetics and environmental factors such as being triggered by a viral infection. MS is usually diagnosed based on the presenting signs and symptoms and the results of supporting medical tests.There is no known cure for multiple sclerosis. Treatments attempt to improve function after an attack and prevent new attacks. Medications used to treat MS, while modestly effective, can have side effects and be poorly tolerated. Physical therapy can help with people's ability to function. Many people pursue alternative treatments, despite a lack of evidence of benefit. The long-term outcome is difficult to predict, with good outcomes more often seen in women, those who develop the disease early in life, those with a relapsing course, and those who initially experienced few attacks. Life expectancy is on average 5 to 10 years lower than that of an unaffected population.Multiple sclerosis is the most common immune-mediated disorder affecting the central nervous system. In 2015, about 2.3 million people were affected globally with rates varying widely in different regions and among different populations. That year about 18,900 people died from MS, up from 12,000 in 1990. The disease usually begins between the ages of 20 and 50 and is twice as common in women as in men. MS was first described in 1868 by Jean-Martin Charcot. The name multiple sclerosis refers to the numerous scars (sclerae—better known as plaques or lesions) that develop on the white matter of the brain and spinal cord. A number of new treatments and diagnostic methods are under development.

More about Multiple Sclerosis